LAP-BAND AP Early Experience Trial (APEX) - Full Text View

Home Search Study Topics Glossary

LAP-BAND AP Early Experience Trial (APEX)

This study is currently recruiting participants.

Verified by Allergan Medical, December 2008

Sponsored by:	Allergan Medical
Information provided by:	Allergan Medical
ClinicalTrials.gov Identifier:	NCT00501085

Purpose

The primary objective of this study is to evaluate the LAP-BAND AP System in severely obese patients.

Condition
Obesity, Morbid

MedlinePlus related topics: Obesity

Study Type:	Observational
Study Design:	Case-Only, Prospective

Further study details as provided by Allergan Medical:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	500
Study Start Date:	June 2007
Estimated Study Completion Date:	September 2013

Eligibility

Study Population

Community sample

Criteria

Inclusion Criteria:

Patient is scheduled to receive the LAP-BAND AP System
Willingness to follow protocol requirements including ICF, HIPAA forms, follow-up schedule, complete patient questionnaires

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00501085

Contacts

Contact: Allergan Medical

Locations

United States, California
Allergan Medical	Recruiting
Los Angeles, California, United States
Contact: Allergan Medical lapband_ap@allergan.com

Sponsors and Collaborators

Allergan Medical

Investigators

Study Director:

Allergan Medical

More Information

Responsible Party:	Allergan ( Allergan Medical )
Study ID Numbers:	MedAff-LBAP201
Study First Received:	July 11, 2007
Last Updated:	December 8, 2008
ClinicalTrials.gov Identifier:	NCT00501085
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Body Weight
Signs and Symptoms
Obesity
Nutrition Disorders

Overweight
Overnutrition
Obesity, Morbid

ClinicalTrials.gov processed this record on January 14, 2009